Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

• Status: Completed
• Trial end date: 2019-07-21

Summary

The goal of this clinical research study is to learn if it is possible to collect stem cells after ofatumumab and chemotherapy treatment. This study will also evaluate side-effects, number of stem cells collected, and the number of procedures that are needed to collect enough stem cells.

• Phase: Phase 2

Details

• Lead Sponsor: M.D. Anderson Cancer Center
• Collaborator: Novartis
• Treatments: Antibodies, Monoclonal; Etoposide; Etoposide phosphate; Ifosfamide; Isophosphamide mustard; Lenograstim; Mesna; Ofatumumab; Sargramostim